134 related articles for article (PubMed ID: 38233086)
1. Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta-analysis.
Zhu J; Xia Y; Liu X; Zhang C
J Gastroenterol Hepatol; 2024 Apr; 39(4):642-648. PubMed ID: 38233086
[TBL] [Abstract][Full Text] [Related]
2. Concurrent spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A systematic review and meta-analysis.
Yang M; Qiu Y; Wang W
Dig Liver Dis; 2024 Jun; 56(6):978-985. PubMed ID: 37926635
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
Wu W; Zhang H; Zeng Z; Wang X; Kong D
Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.
Qi X; Han G; He C; Yin Z; Zhang H; Wang J; Xia J; Cai H; Yang Z; Bai M; Wu K; Fan D
Med Sci Monit; 2012 Aug; 18(8):HY37-41. PubMed ID: 22847208
[TBL] [Abstract][Full Text] [Related]
5. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial.
Qi X; He C; Yin Z; Wang Z; Zhang H; Yao L; Wang J; Xia J; Cai H; Yang Z; Bai M; Guo W; Niu J; Wu K; Fan D; Han G;
BMJ Open; 2013; 3(7):. PubMed ID: 23847271
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis.
Guo DF; Fan LW; Le Q; Huang CB
Front Pharmacol; 2022; 13():968988. PubMed ID: 36052145
[No Abstract] [Full Text] [Related]
9. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
10. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks.
Zhou Y; Zhang W; Zhang Z; Luo J; Gu J; Liu Q; Ma J; Yan Z; Chen S; Wang J
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1235-1243. PubMed ID: 32744824
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt and splenectomy are more effective than endoscopic therapy for recurrent variceal bleeding in patients with idiopathic noncirrhotic portal hypertension.
He FL; Qi RZ; Zhang YN; Zhang K; Zhu-Ge YZ; Wang M; Wang Y; Jia JD; Liu FQ
World J Clin Cases; 2020 May; 8(10):1871-1877. PubMed ID: 32518776
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL
World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143
[TBL] [Abstract][Full Text] [Related]
13. Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis.
Zhou GP; Sun LY; Wei L; Qu W; Zeng ZG; Liu Y; Jiang YZ; Zhu ZJ
Chin Med J (Engl); 2019 May; 132(9):1087-1099. PubMed ID: 30913064
[TBL] [Abstract][Full Text] [Related]
14. TIPSS plus extrahepatic collateral embolisation may decrease variceal rebleeding and post-TIPSS hepatic encephalopathy.
Zhao L; Wu Q; Li Q; Chen A; Xia Y; Sun X; Jia J; Shan S; Wang G; Zhang C
Gut; 2024 Jun; 73(7):1224-1226. PubMed ID: 37524443
[No Abstract] [Full Text] [Related]
15. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
[TBL] [Abstract][Full Text] [Related]
17. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
[TBL] [Abstract][Full Text] [Related]
18. Transjugular Intrahepatic Portosystemic Shunt With or Without Gastroesophageal Variceal Embolization for the Prevention of Variceal Rebleeding: A Systematic Review and Meta-Analysis.
Jaber F; Beran A; Alsakarneh S; Ahmed K; Abdallah M; Elfert K; Almeqdadi M; Jaber M; Mohamed WT; Ahmed M; Al Momani L; Numan L; Bierman T; Helzberg JH; Ghoz H; Clarkston WK
Gastroenterology Res; 2023 Apr; 16(2):68-78. PubMed ID: 37187555
[TBL] [Abstract][Full Text] [Related]
19. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.
Xu X; Guo X; De Stefano V; Silva-Junior G; Goyal H; Bai Z; Zhao Q; Qi X
Hepatol Int; 2019 Jul; 13(4):468-481. PubMed ID: 31175581
[TBL] [Abstract][Full Text] [Related]
20. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
